Quanta Lite GP210 Elisa
Autoantibodies, Nuclear Pore Glycoprotein Gp210. 510(k) K040885, from Inova Diagnostics, Inc. (San Diego, CA). Product code NRI, class 2.
As of Nov 21, 2026, K040885 is an FDA 510(k) held by Inova Diagnostics, Inc., substantially equivalent on Jun 25, 2004 after 81 days, with no recalls tied to it in FDA's recall database.
- Review time: 81 days
- Recalls: 0
- Cited as a predicate by: 1 device
The QUANTA Liteâ„¢ gp210 kit is an enzyme-linked immunosorbent assay (ELISA) for the semi-quantitative detection of anti-gp210 antibody of the IgG class in human serum. This test is intended to aid in the diagnosis of primary biliary cirrhosis (PBC).
- Euroimmun Euroline Profile Autoimmune Liver Disease 8AG (Igg)K113439 · Euroimmun US · Apr 12, 2013
- Type
- Traditional
- Received
- Apr 5, 2004
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5090
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files